A detailed history of Uss Investment Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Uss Investment Management LTD holds 484,163 shares of ABBV stock, worth $87.1 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
484,163
Previous 485,923 0.36%
Holding current value
$87.1 Million
Previous $83.3 Million 14.72%
% of portfolio
0.72%
Previous 0.68%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $288,358 - $350,820
-1,760 Reduced 0.36%
484,163 $95.6 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $1.25 Million - $1.46 Million
8,092 Added 1.69%
485,923 $83.3 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $677,956 - $772,468
4,242 Added 0.9%
477,831 $87 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $4.24 Million - $4.77 Million
-30,806 Reduced 6.11%
473,589 $73.4 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $1.74 Million - $2.01 Million
12,989 Added 2.64%
504,395 $75.2 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $1.1 Million - $1.37 Million
8,281 Added 1.71%
491,406 $66.2 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $1.45 Million - $1.68 Million
10,059 Added 2.13%
483,125 $77 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $167,631 - $201,034
-1,212 Reduced 0.26%
473,066 $76.5 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $17.4 Million - $20 Million
-129,969 Reduced 21.51%
474,278 $63.7 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $3.62 Million - $4.61 Million
-26,322 Reduced 4.17%
604,247 $92.7 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $1.94 Million - $2.4 Million
14,675 Added 2.38%
630,569 $102 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $6.65 Million - $7.55 Million
62,546 Added 11.3%
615,894 $66.4 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $3.52 Million - $4.76 Million
-43,762 Reduced 7.33%
553,348 $59.2 Million
Q3 2020

Oct 30, 2020

BUY
$85.91 - $100.83 $187,799 - $220,414
2,186 Added 0.37%
597,110 $52.3 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $21.6 Million - $28.9 Million
294,804 Added 98.23%
594,924 $58.4 Million
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $17 Million - $25.7 Million
263,220 Added 713.33%
300,120 $22.8 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $2.66 Million - $3.33 Million
36,900 New
36,900 $3.27 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.